Is Evogene Stock a Good Investment?

Evogene Investment Advice

EVGN

To provide specific investment advice or recommendations on Evogene stock, we recommend investors consider the following general factors when evaluating Evogene. This will help you to make an informed decision on whether to include Evogene in one of your diversified portfolios:

Examine Evogene's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
Research Evogene's leadership team and their track record. Good management can help Evogene navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
Consider the overall health of the Chemicals space and any emerging trends that could impact Evogene's business and its evolving consumer preferences.
Compare Evogene's performance and market position to its competitors. Analyze how Evogene is positioned in terms of product offerings, innovation, and market share.
Check if Evogene pays a dividend and its dividend yield and payout ratio.
Review what financial analysts are saying about Evogene's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.

It's important to note that investing in Evogene stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if Evogene is a good investment.

Sell

Buy

Hold

We provide trade advice to complement the prevailing expert consensus on Evogene. Our dynamic recommendation engine uses a multidimensional algorithm to analyze the company's potential to grow using all technical and fundamental data available at the time. To make sure Evogene is not overpriced, please confirm all Evogene fundamentals, including its price to book, current ratio, retained earnings, as well as the relationship between the net income and target price . Given that Evogene is a hitting penny stock territory we advise to closely look at its number of shares shorted.

Market Performance	Insignificant	Details
Volatility	Dangerous	Details
Hype Condition	Stale	Details
Current Valuation	Undervalued	Details
Odds Of Distress	Very High	Details
Economic Sensitivity	Almost mirrors the market	Details
Investor Sentiment	Alarmed	Details
Analyst Consensus	Not Available	Details
Financial Leverage	Not Rated	Details
Reporting Quality (M-Score)	Unavailable	Details

Examine Evogene Stock

Researching Evogene's stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). The company recorded a loss per share of 2.89. Evogene had not issued any dividends in recent years. The entity had 1:10 split on the 25th of July 2024.

To determine if Evogene is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Evogene's research are outlined below:

	Evogene may become a speculative penny stock
	Evogene had very high historical volatility over the last 90 days
	Evogene has a very high chance of going through financial distress in the upcoming years
	The company reported the previous year's revenue of 5.64 M. Net Loss for the year was (25.95 M) with profit before overhead, payroll, taxes, and interest of 5.83 M.
	Evogene currently holds about 35.25 M in cash with (21.58 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.86.

Evogene uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Evogene. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Evogene's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.

	14th of March 2024 Upcoming Quarterly Report	View
	16th of May 2024 Next Financial Report	View
	31st of December 2023 Next Fiscal Quarter End	View
	14th of March 2024 Next Fiscal Year End	View
	30th of September 2023 Last Quarter Report	View
	31st of December 2022 Last Financial Announcement	View

Evogene's market capitalization trends

The company currently falls under 'Nano-Cap' category with a current market capitalization of 9.72 M.

Evogene's profitablity analysis

The company has Profit Margin (PM) of (1.94) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (2.83) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $2.83.

Determining Evogene's profitability involves analyzing its financial statements and using various financial metrics to determine if Evogene is a good buy. For example, gross profit margin measures Evogene's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Evogene's profitability and make more informed investment decisions.

Basic technical analysis of Evogene Stock

As of the 20th of March, Evogene shows the Mean Deviation of 3.51, coefficient of variation of 2318.3, and Downside Deviation of 3.83. Evogene technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices.

Evogene's Outstanding Corporate Bonds

Evogene issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Evogene uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Evogene bonds can be classified according to their maturity, which is the date when Evogene has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

	Morgan Stanley 3591 Corp Bond US61744YAK47	View
	Valero Energy Partners Corp Bond US91914JAA07	View
	MPLX LP 4875 Corp Bond US55336VAJ98	View
	MPLX LP 52 Corp Bond US55336VAL45	View

View All Evogene Corporate Bonds

Understand Evogene's technical and predictive indicators

Using predictive indicators to make investment decisions involves analyzing Evogene's various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.

	Risk Adjusted Performance	0.0465
	Market Risk Adjusted Performance	0.2351
	Mean Deviation	3.51
	Semi Deviation	3.37
	Downside Deviation	3.83
	Coefficient Of Variation	2318.3
	Standard Deviation	4.96
	Variance	24.56
	Information Ratio	0.0562
	Jensen Alpha	0.2716
	Total Risk Alpha	0.6222
	Sortino Ratio	0.0727
	Treynor Ratio	0.2251
	Maximum Drawdown	23.77
	Value At Risk	(6.37)
	Potential Upside	10.56
	Downside Variance	14.69
	Semi Variance	11.38
	Expected Short fall	(5.39)
	Skewness	1.28
	Kurtosis	2.47

	Risk Adjusted Performance	0.0465
	Market Risk Adjusted Performance	0.2351
	Mean Deviation	3.51
	Semi Deviation	3.37
	Downside Deviation	3.83
	Coefficient Of Variation	2318.3
	Standard Deviation	4.96
	Variance	24.56
	Information Ratio	0.0562
	Jensen Alpha	0.2716
	Total Risk Alpha	0.6222
	Sortino Ratio	0.0727
	Treynor Ratio	0.2251
	Maximum Drawdown	23.77
	Value At Risk	(6.37)
	Potential Upside	10.56
	Downside Variance	14.69
	Semi Variance	11.38
	Expected Short fall	(5.39)
	Skewness	1.28
	Kurtosis	2.47

Consider Evogene's intraday indicators

Evogene intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Evogene stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

	Accumulation Distribution	1278.7
	Daily Balance Of Power	(0.62)
	Rate Of Daily Change	0.97
	Day Median Price	1.37
	Day Typical Price	1.37
	Price Action Indicator	(0.01)
	Period Momentum Indicator	(0.05)
	Relative Strength Index	50.25

Evogene time-series forecasting models is one of many Evogene's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Evogene's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Evogene Stock media impact

Far too much social signal, news, headlines, and media speculation about Evogene that are available to investors today. That information is available publicly through Evogene media outlets and privately through word of mouth or via Evogene internal channels. However, regardless of the origin, that massive amount of Evogene data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.

A primary focus of Evogene news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Evogene relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Evogene's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Evogene alpha.

Evogene Corporate Management

Rachel Gerber	Head Relations	Profile
Russ Putland	Vice Ltd	Profile
Amit res	Chief Ltd	Profile
Dan Gelvan	Chief Ltd	Profile
Dotan Borenstein	Chief Ltd	Profile
Yaron Eldad	Chief Officer	Profile

When determining whether Evogene offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Evogene's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Evogene Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Evogene Stock: